Ambuja Cements Q3 FY26 results: Revenue up 21% YoY, PAT down on one-offs and exceptional items

Revenue Growth 20pctExceptional ItemEmphasis Of MatterRelated Party TransactionsResults View source PDF Explain this filing

AMBUJACEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Reaction day

₹536.00

prior close

₹521.70

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.5%-4.5% vs market

Cement & Cement Products peers, median of 34sector-0.2%-4.7% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty 100 and 4.7 pts less than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-1.1

15m

-1.8

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.9-0.5-4.5-0.2-4.7

Next day

-4.7-1.4-3.3-1.0-3.7

-1.5+1.1-2.6+0.4-1.9

+0.0+1.4-1.4+2.5-2.5

-0.7+0.9-1.5+1.8-2.4

-1.5+1.1-2.6+0.7-2.1

+0.5+2.0-1.6+2.9-2.4

15d

-4.2+0.8-4.9-2.0-2.2

-8.2-1.8-6.5-5.1-3.1

-25.1-12.1-13.0-21.1-4.0

-17.2-4.3-12.8-4.9-12.2

UpDownMarket · Nifty 100Sector · Cement & Cement Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ambuja Cements Q3 FY26 standalone revenue rose 21% YoY to Rs 5,908.67 Cr from Rs 4,888.41 Cr. PAT dropped sharply to Rs 203.99 Cr vs Rs 1,758.03 Cr, hit by lower other income, no big tax write-back this quarter (unlike Q3 FY25), and Rs 35.37 Cr exceptional expense. 9M FY26 revenue grew 23% YoY to Rs 16,588.65 Cr. Consolidated Q3 revenue at Rs 10,180.52 Cr, up 20% YoY.

Likely market impact

Strong revenue growth driven by acquisitions, but PAT hit by one-offs and higher costs. MD retirement and CCI case are key watch items.